E Fund Management’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$296K Buy
+32,897
New +$519K 0.01% 397
2025
Q2
$541K Buy
29,683
+8,811
+42% +$180K 0.03% 218
2025
Q1
$414K Sell
20,872
-15,597
-43% -$270K 0.02% 246
2024
Q4
$625K Buy
36,469
+11,351
+45% +$214K 0.03% 194
2024
Q3
$502K Buy
25,118
+8,120
+48% +$126K 0.03% 195
2024
Q2
$190K Sell
16,998
-15,243
-47% -$128K 0.01% 295
2024
Q1
$213K Buy
32,241
+3,181
+11% +$17.4K 0.01% 333
2023
Q4
$131K Sell
29,060
-3,069
-10% -$11.4K 0.01% 297
2023
Q3
$115K Sell
32,129
-6,484
-17% -$25K 0.01% 277
2023
Q2
$142K Sell
38,613
-17,090
-31% -$63.3K 0.01% 290
2023
Q1
$184K Buy
55,703
+14,327
+35% +$49.5K 0.01% 309
2022
Q4
$161K Buy
41,376
+1,518
+4% +$4.68K 0.01% 311
2022
Q3
$97K Buy
+39,858
New +$95.6K 0.01% 328

Other funds holding ADMA